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A 70 year-old man with Parkinson’s disease (PD) of nearly 
20 years’ duration decided to see an acupuncturist for another 
opinion on the treatment of his PD. He was prescribed a series 
of herbal teas as well as 12 weeks of Chinese acupuncture. 
Following this treatment he felt better, not in terms of his 
motor symptoms, but because the teas relieved his chronic 
constipation. He was so delighted with the removal of this 
symptom that he questioned the need for PD medications, 
which amounted to total daily doses of 750 mg levodopa, 9 mg 
ropinirol, and 300 mg amantadine. Without consulting his 
neurologist, he abruptly decreased each of the prescribed doses 
by two-thirds. Shortly afterwards, he stumbled and fell on a tile 
floor, resulting in a sharp pain in the right groin radiating to the 
medial thigh. Radiographic evaluation of the right hip revealed 
an impacted right garden II femoral neck fracture, for which 
he underwent percutaneous pinning (Fig. 1). 
Multiple factors contribute to the risk of falls for persons 
with parkinsonism. Hallmark symptoms of bradykinesia, 
rigidity, and postural instability may apply to all forms of 
parkinsonism. Neurogenic orthostatic hypotension is a mani-
festation of autonomic dysfunction that may lead to falls and is 
more common with parkinsonism due to synuclein pathology, 
such as PD or multiple system atrophy [1, 2]. Some persons 
with parkinsonism may have extraocular eye movement ab-
normalities, further increasing their risk of falling. This occurs 
most often in progressive supranuclear palsy and is thought to 
play a role in the ‘early falls’ often reported by patients at the 
time of diagnosis. Our patient had no evidence of orthostatic 
intolerance or eye movement abnormalities surrounding the 
time of his fall. He did however suffer from frequent freezing of 
gait (FOG) in addition to his tremor, bradykinesia, and rigidity, 
which led to his high intensity dopamine supplementation. 
While persons with PD are at risk of falling, those with less 
mobility/core strength and declining bone density (which may 
follow reductions in dopaminergic therapy), are at increased 
risk for not only falls, but also significant injury and morta-
lity stemming from subsequent surgery and complications 
[3, 4]. Furthermore, there is an increased risk of fractures 
among patients with PD and dementia compared to those 
without dementia; however, this risk is not solely explained 
by the presence of dementia [5]. Vitamin D deficiency and 
perhaps bone loss may also contribute to this risk. It has even 
been proposed that low vitamin D levels may be related to 
the pathomechanism underlying PD [6]. Our patient had no 
cognitive impairment at the time of his fall, but was diagnosed 
with osteopenia shortly thereafter.
The cornerstone of treatment for PD is dopamine supple-
mentation via levodopa, which improves motor symptoms of 
resting tremor, bradykinesia, and rigidity. Other symptoms 
associated with more advanced disease states, such as postural 
instability and FOG, are recalcitrant to dopaminergic thera-
pies. However, there is secondary improvement in ambulation 
probably due to decreased bradykinesia and rigidity. 
In advanced stages of PD, patients may begin to think that 
their medication has lost its effectiveness due to an accumu-
lation of ‘dopa-resistant’ symptoms. It can be tempting for 
patients, with or without the guidance of their neurologist, to 
seek a simplified medication regimen and decrease dosage or 
frequency of dopaminergic drug therapy. In the case of our 
patient, this decision was catalyzed by the assumption that the 
improvement of non-motor symptoms indicated a concomi-
tant improvement of motor symptoms. Our patient’s expe-
rience vividly illustrates how abruptly altering dopaminergic 
medications can have disastrous consequences. 
In addition to emphasising the critical role of dopamine 
supplementation in PD, this case teaches us an important 
lesson that non-motor symptoms of PD deserve attention. 
Such symptoms, including constipation, affect up to 90% of 
PD patients [7]. In his Essay on the Shaking Palsy, James Par-
kinson wrote: “The bowels, which had been all along torpid, 
391www.journals.viamedica.pl/neurologia_neurochirurgia_polska
Philip W. Tipton, ‘Falling off’ the dopamine wagon
now, in most cases, demand stimulating medicines of very 
considerable power” [8]. Treating such non-motor symptoms 
may not only improve quality of life, but avoid catastrophe.
Because PD is classically thought of as a disorder of mo-
vement, patients may be less likely to mention non-motor 
symptoms in the setting of a neurological follow up visit, unless 
explicitly questioned on the topic by their neurologist. Due to 
the complexity of PD, this can be a challenge to accomplish wit-
hin the confines of a short office visit. However, its importance 
cannot be overstated because many non-motor symptoms 
such as mood disorders, cognitive impairment, and autono-
mic dysfunction have a negative impact on quality of life [9]. 
This case underscores the importance of a strong thera-
peutic alliance in which patients are comfortable discussing 
these issues and therapy options they may be considering. 
Our patient pursued a non-traditional approach with Eastern 
medicine, which he credited with improving his constipation, 
and that led him to reduce his dopaminergic medications. 
Discussing the option of supplementing rather than replacing 
his medications might have prevented his injury.
Fortunately, our patient’s fall resulted in morbidity that 
was repairable. It is advisable to stress to patients and caregi-
vers not to decrease dopaminergic therapy, even in advanced 
PD, unless serious adverse effects develop. In such instances, 
considering alternative forms of treatment (i.e. medications 
and surgery) may be appropriate. 
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Figure 1. Pelvic X-ray. A. Pelvic X-ray of a 70 year-old man showing right garden II femoral neck fracture (black arrowhead); B. Follow-up 
pelvic X-ray after surgical repair with pinning
